Most drug development (preclinical and clinical) in diseases with 10 million or more cases per year.
Kirk W. Kerr
Thomas C. Henry
Kathleen L. Miller
10.1371/journal.pntd.0006695.g004
https://plos.figshare.com/articles/figure/Most_drug_development_preclinical_and_clinical_in_diseases_with_10_million_or_more_cases_per_year_/6950387
<p>Most drug development (preclinical and clinical) in diseases with 10 million or more cases per year.</p>
2018-08-09 17:30:02
drug development
priority review voucher program
disease priority review voucher program